Orthopedic Surgery Doctors in Little Falls, MN Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

David Jorgensen, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1108 1st St Se, Little Falls, MN 56345 Phone: 320-631-2200    Fax: 320-632-3728

Mr. Virgil Meyer, D.O. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1108 1st St Se, Little Falls, MN 56345 Phone: 320-631-2200    Fax: 320-632-3728

David Earl Edgerton Jr., D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1108 1st St Se, Little Falls, MN 56345 Phone: 320-631-2200    Fax: 320-632-3728

Dr. Paul Ryan Johnson, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1108 1st St Se, Little Falls, MN 56345 Phone: 320-631-2200    Fax: 320-632-3728

Philip L Prosapio, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1108 1st St Se, Little Falls, MN 56345 Phone: 320-631-2200    Fax: 320-632-3728

News Archive

New website helps people to endure difficult situations through inspirational stories

A new inspirational stories website, 'GotInspiration.org,' is connecting those who have endured some of life's most difficult situations with those who are looking for inspiration. From quitting drinking to managing post traumatic stress disorder, to surviving cancer, GotInspiration.org is helping people find inspiration and strength, one true story at a time.

Tyco declares quarterly dividend of CHF 0.22 per share

The Board of Directors of Tyco International Ltd. today declared a quarterly dividend of 0.22 Swiss Francs (CHF) per share, payable on August 25, 2010 to shareholders of record at the close of business on July 30, 2010, subject to a required filing with the Swiss Commercial Register.

Laser pointer exposure causes eye injuries

In recent years, a substantial increase in the number of eye injuries caused by laser pointers has been observed, especially in children and adolescents.

MDRNA granted Chinese patent for use of nucleic acids in cancer treatment

MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.

Read more Medical News

› Verified 3 days ago